Wednesday, April 05, 2023
UM School of Medicine Researchers Chart Path Forward on Developing mRNA Vaccines for Infections Beyond COVID-19
After helping to develop and test new mRNA technologies for COVID-19 vaccines, University of Maryland School of Medicine (UMSOM) researchers and scientists are turning their attention to utilizing this innovative technology to ward off other infectious diseases like malaria and influenza. Last month, UMSOM faculty in the Center for Vaccine Development and Global Health (CVD) launched a new clinical trial to investigate the use of mRNA technologies to create a vaccine against malaria. CVD Director Kathleen M. Neuzil, MD, MPH, FIDSA also provided commentary in the nation’s leading medical journal on the feasibility of using mRNA to develop a universal influenza vaccine that could eliminate the need for seasonal shots.
Wednesday, April 05, 2023
Understanding E. Coli Strains That Do Not Cause Diarrhea Could Lead to New Treatments
News reports featuring E. coli often tell terrifying stories of intestinal illness and diarrhea or deadly outbreaks from contaminated food. There are, however, many different strains of the bacteria E. coli, or Escherichia coli, and not all are bad.
Tuesday, April 04, 2023
UM School of Medicine Study Finds ChatGPT Helpful for Breast Cancer Screening Advice, With Certain Caveats
As more consumers turn to the newly available ChatGPT for health advice, researchers are eager to see whether the information provided by the artificial intelligence chatbot is reliable and accurate. A new study conducted by researchers at the University of Maryland School of Medicine (UMSOM) indicates that the answers generated provide correct information the vast majority of the time; sometimes, though, the information is inaccurate or even fictitious.
Friday, March 31, 2023
Traumatic Brain Injury Interferes with Immune System Cells’ Recycling Process in Brain Cells
Each year about 1.5 million people in the U.S. survive a traumatic brain injury due to a fall, car accident, or a sports injury, which can cause immediate and long-term disability.
Tuesday, March 28, 2023
Two-Time Lasker Awardee and Internationally Acclaimed Virologist, Robert C. Gallo, MD, To Step Down as Director of UM School of Medicine’s Institute of Human Virology (IHV)
Robert C. Gallo, MD, one of the world’s leading virologists and cancer researchers, announced he has stepped down from his position as Director of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM), effective March 24.
Thursday, March 09, 2023
Leading Physician-Scientist Dr. William F. Regine Named Senior Associate Dean for Clinical Affairs at UM School of Medicine and President of UM Faculty Physicians, Inc.
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD announced today that William F. Regine, MD, FACR, FASTRO, FACRO has been appointed to the executive role of Senior Associate Dean for Clinical Affairs at the University of Maryland School of Medicine (SOM), effective immediately.
.jpg)
Wednesday, March 01, 2023
Internationally-Renowned Scientist Claire Fraser, PhD, To Step Down as Director of the University of Maryland School of Medicine's Institute for Genome Sciences
Claire Fraser, PhD, a pioneer and global leader in genomic research, has announced that she will step down from her position as Director of the Institute for Genome Sciences (IGS) in the University of Maryland School of Medicine (UMSOM). She will now continue as the Dean E. Albert Reece Endowed Professor and Professor of Medicine and Microbiology and Immunology at UMSOM and scientist at IGS until she retires in 2024.
Thursday, February 23, 2023
Baltimore PKD Research and Clinical Core Center Receives Prestigious ‘Center of Excellence’ Designation from PKD Foundation
The PKD Foundation recently recognized the University of Maryland School of Medicine’s (UMSOM) clinical center that treats polycystic kidney disease (PKD)with a highly prestigious “Center of Excellence” designation. The designation recognizes the center as a leader in providing multidisciplinary, comprehensive clinical services for families affected by autosomal dominant polycystic kidney disease (ADPKD), a hereditary condition. It is one of just 28 clinical centers in the U.S.to receive this recognition.
Wednesday, February 22, 2023
Parkinson’s Disease Patients Experience Significant Reduction in Symptoms with Non-Surgical Focused Ultrasound Treatment
Patients with Parkinson’s disease achieved a significant improvement in their tremors, mobility, and other physical symptoms after having a minimally invasive procedure involving focused ultrasound, according to a new study today published in the New England Journal of Medicine.
Wednesday, February 22, 2023
The Molecular Mechanism Behind Abdominal Aneurysms
When the artery that supplies the stomach and the liver forms a bulge that ruptures, this medical emergency results in the deaths of 50 percent of patients before they reach the hospital. This “silent killer” condition, known as abdominal aortic aneurysm , led to the death of Albert Einstein — and is responsible for nearly 5,000 deaths in the U.S. each year. Now researchers have found new clues that eventually could lead to earlier detection methods to save lives in the future.